
### [NCIT:C90525](http://purl.obolibrary.org/obo/NCIT_C90525)
**Label:** Pharyngeal Carcinoma by AJCC v6 Stage

**Subclasses:** [NCIT:C6039](http://purl.obolibrary.org/obo/NCIT_C6039) (Stage 0 Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C7920](http://purl.obolibrary.org/obo/NCIT_C7920) (Stage II Nasopharyngeal Carcinoma AJCC v6), [NCIT:C8218](http://purl.obolibrary.org/obo/NCIT_C8218) (Stage II Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C8217](http://purl.obolibrary.org/obo/NCIT_C8217) (Stage I Oropharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C8533](http://purl.obolibrary.org/obo/NCIT_C8533) (Stage IV Hypopharyngeal Carcinoma AJCC v6), [NCIT:C6035](http://purl.obolibrary.org/obo/NCIT_C6035) (Stage 0 Nasopharyngeal Undifferentiated Carcinoma AJCC v6, v7, and v8), [NCIT:C8038](http://purl.obolibrary.org/obo/NCIT_C8038) (Stage I Hypopharyngeal Carcinoma AJCC v6), [NCIT:C8039](http://purl.obolibrary.org/obo/NCIT_C8039) (Stage II Hypopharyngeal Carcinoma AJCC v6 and v7), [NCIT:C6036](http://purl.obolibrary.org/obo/NCIT_C6036) (Stage 0 Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v6, v7, and v8), [NCIT:C9101](http://purl.obolibrary.org/obo/NCIT_C9101) (Stage 0 Hypopharyngeal Carcinoma AJCC v6, v7, and v8), [NCIT:C8233](http://purl.obolibrary.org/obo/NCIT_C8233) (Stage II Hypopharyngeal Squamous Cell Carcinoma AJCC v6 and v7), [NCIT:C4590](http://purl.obolibrary.org/obo/NCIT_C4590) (Stage 0 Oropharyngeal Carcinoma AJCC v6 and v7), [NCIT:C8040](http://purl.obolibrary.org/obo/NCIT_C8040) (Stage III Hypopharyngeal Carcinoma AJCC v6), [NCIT:C9218](http://purl.obolibrary.org/obo/NCIT_C9218) (Stage IV Oropharyngeal Carcinoma AJCC v6), [NCIT:C8049](http://purl.obolibrary.org/obo/NCIT_C8049) (Stage II Oropharyngeal Carcinoma AJCC v6 and v7), [NCIT:C6048](http://purl.obolibrary.org/obo/NCIT_C6048) (Stage 0 Hypopharyngeal Squamous Cell Carcinoma AJCC v6, v7, and v8), [NCIT:C8048](http://purl.obolibrary.org/obo/NCIT_C8048) (Stage I Oropharyngeal Carcinoma AJCC v6 and v7), [NCIT:C7395](http://purl.obolibrary.org/obo/NCIT_C7395) (Stage I Nasopharyngeal Carcinoma AJCC v6), [NCIT:C115087](http://purl.obolibrary.org/obo/NCIT_C115087) (Stage II Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C115086](http://purl.obolibrary.org/obo/NCIT_C115086) (Stage I Oropharyngeal Undifferentiated Carcinoma AJCC v6 and v7), [NCIT:C9099](http://purl.obolibrary.org/obo/NCIT_C9099) (Stage 0 Nasopharyngeal Carcinoma AJCC v6, v7, and v8), [NCIT:C7397](http://purl.obolibrary.org/obo/NCIT_C7397) (Stage IV Nasopharyngeal Carcinoma AJCC v6), [NCIT:C7396](http://purl.obolibrary.org/obo/NCIT_C7396) (Stage III Nasopharyngeal Carcinoma AJCC v6), [NCIT:C90522](http://purl.obolibrary.org/obo/NCIT_C90522) (Nasopharyngeal Carcinoma by AJCC v6 Stage), [NCIT:C8050](http://purl.obolibrary.org/obo/NCIT_C8050) (Stage III Oropharyngeal Carcinoma AJCC v6), [NCIT:C90524](http://purl.obolibrary.org/obo/NCIT_C90524) (Hypopharyngeal Carcinoma by AJCC v6 Stage), [NCIT:C90523](http://purl.obolibrary.org/obo/NCIT_C90523) (Oropharyngeal Carcinoma by AJCC v6 Stage), 

**Class expressions from DL-Learner:**

- [NCIT:C90529](http://purl.obolibrary.org/obo/NCIT_C90529) (AJCC v6 Stage) 53.57%
- Thing 53.00%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39802](http://purl.obolibrary.org/obo/NCIT_C39802) (Renal Cell Carcinoma Associated with inv(X)(p11;q12)))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39801](http://purl.obolibrary.org/obo/NCIT_C39801) (inv(X)(p11;q12)))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39800](http://purl.obolibrary.org/obo/NCIT_C39800) (Sickle Cell Trait))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39799](http://purl.obolibrary.org/obo/NCIT_C39799) (Loss of Chromosome 21))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39798](http://purl.obolibrary.org/obo/NCIT_C39798) (Loss of Chromosome 2))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39795](http://purl.obolibrary.org/obo/NCIT_C39795) (Loss of Chromosome 14q))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39788](http://purl.obolibrary.org/obo/NCIT_C39788) (MET Gene Mutation))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39787](http://purl.obolibrary.org/obo/NCIT_C39787) (Multiple Tumor Masses))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39786](http://purl.obolibrary.org/obo/NCIT_C39786) (Bilateral Disease))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39783](http://purl.obolibrary.org/obo/NCIT_C39783) (Retinal Hemangioblastoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39752](http://purl.obolibrary.org/obo/NCIT_C39752) (Refractory Disease))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39751](http://purl.obolibrary.org/obo/NCIT_C39751) (Glioblastoma, IDH-Mutant))) 38.93%


